March 25, 2010 | By Allison Cerra NEW YORK An experimental vaccine against an abnormal protein found in some tumors has the potential to delay the onset of inflammatory bowel disease and in turn prevent progression to colon cancer, according to researchers at the University of Pittsburgh School of Medicine.People with such chronic inflammatory disorders as IBD are at greater risk for developing ca